Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)

2024-12-13

中文

英语 (English)

所属地区： --

所属机构： --

Published date: 13 December 2024

Open future opportunity - This means that the buyer is not yet ready to invite bid applications but early notification has been provided and some dialogue may be possible.

Watch this notice Print this notice

Contract summary

Industry

Vaccines - 33651600

Location of contract

United Kingdom

Value of contract

£0

Procurement reference

CF-2690900D0O000000rwimUAA

Published date

13 December 2024

Approach to market date

31 January 2025

Contract start date

1 October 2025

Contract end date

30 September 2029

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

What is an open procedure (above threshold)?

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Contract is suitable for VCSEs?

Description

The provision of a vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.
The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 11.5 million doses of vaccine. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
The opportunity is not split into lots.

More information

Attachments: Published PIN.pdf

Published PIN

How to apply

Follow the instructions given in the description or the more information section.

About the buyer

Contact name

Chantal Jockel

Address

10 South Colonnade
London
E14 4PU
GB

Email

vmc.vaccines@ukhsa.gov.uk

Share this notice

Twitter

Is there anything wrong with this page?